Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Medtronic Neuromodulation
483
•Medtronic Neuromodulation•May 5, 2023

Medtronic Neuromodulation – FDA 483, May 5, 2023

Record Details

Medtronic Neuromodulation, located in Minneapolis, MN, underwent an FDA inspection from April 18 to May 5, 2023. The resulting Form 483 detailed four major areas of concern regarding the company's quality systems and safety reporting for its implantable neurostimulation devices. A primary violation involved the failure to notify the FDA within the required 10-day timeframe regarding product corrections and removals. Specifically, the company updated product labeling and initiated field resets to address electrical damage and communication failures but did not report these actions as required. Additionally, the FDA found that Medtronic's internal procedures for reporting medical device malfunctions were inadequate, leading to delays in reporting significant events, such as patient burns during device recharging. The inspection also highlighted deficiencies in the company's Corrective and Preventive Action (CAPA) processes. Medtronic failed to timely extend corrective measures to all affected product families even after confirming similar risks across different models and failed to address all identified root causes. Furthermore, the firm did not adequately investigate new complaints, often relying on outdated studies that did not apply to newer device designs. These observations were issued under the Federal Food, Drug, and Cosmetic Act. While the document is not a final determination of compliance, it serves as a formal notice of objectionable conditions. Medtronic has promised to correct all noted deficiencies and is responsible for conducting internal audits to ensure the long-term effectiveness of these corrective actions.

Company
Medtronic Neuromodulation
Inspection date
May 5, 2023
Product type
devices
Office
Minneapolis District Office
People
  • Laiza V. Garcia (investigator)
  • Christina L. Bigham (Investigator )
View Company Profile

ID · 9f2feed5-f25f-45ac-9fc8-f1d258fb0322

Other documents for Medtronic Neuromodulation
  • EIR - 2023-05-05May 5, 2023
  • 483 - 2022-11-03November 3, 2022
  • 483 - 2019-10-17October 17, 2019
  • 483 - 2017-06-30June 30, 2017
  • 483 - 2015-10-26October 26, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medtronic Neuromodulation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.